Hypertrophic signalling Identify contraction-induced growth signals Describe the composition and regulation of mTORC1 Describe the effectors of mTOR Explain.

Slides:



Advertisements
Similar presentations
Regulation of Protein Translation
Advertisements

Insulin Signaling – Insulin Resistance Elmus G. Beale, Professor Texas Tech University Health Sciences Center Paul L. Foster School of Medicine PhD, Baylor.
Signal Transduction Biochemistry – February 23, 2005 Chapter 12 – parts 12.3, 12.4.
Protein Translation Assembly of 5’-cap complex Annealing of ribosome t-RNA decoded polypeptide elongation Trafficking Co-translational modification –Sugars.
Journey of a protein molecule. I: A protein is born 1.Translation 1) What is translation?
Specialized signaling pathways 1: RTK associated pathways
Selected Hormonal Issues Relating to Exercise and Substrate Use.
Insulin and Amino Acid Signaling Through mTOR in Perfused Rat Liver Jessica Biegler.
Date of download: 7/5/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Insulin signaling pathways. The insulin signaling pathways provide.
Regulation of glucose levels in the blood is very important Normal Fasting (Serum) ~ 70 – 100 mg/dl Elevated = Diabetes Low = Hypoglycemia Insulin from.
Cellular hypertrophy Control of protein accretion –Endogenous Nutrient status Functional adequacy History –Exogenous Nutrient availability Growth factors.
Protein Synthesis (Translation)
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Pharmacodynamics III Receptor Families
AMPK – Akt – mTOR AXIS IS A METABOLIC CHECKPOINT OF THE CELL
MYC, Metabolism and Cancer
by Rogelio Zamilpa, and Merry L. Lindsey
Tuberous Sclerosis TSC2/ Tuberin Alison Chappell.
Sustaining Proliferative Signaling and Evading Growth Suppressors
mTOR Signaling in Growth Control and Disease
IRS-1: Auditing the effectiveness of mTOR inhibitors
Figure 1 mTOR pathway activation
The Akt-mTOR tango and its relevance to cancer
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3- Kinase/AKT/Mammalian Target of Rapamycin Pathway  Gozde Akgumus, Fengqi.
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Physiological regulation of autophagy in the heart
Figure 1 mTOR complex biology
Review AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism CELL METABOLISM : JANUARY 2005 · VOL.
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Exercise-induced cardiac hypertrophy: Structural adaptation
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Identification of TOR Signaling Complexes
Is REDD1 a Metabolic Éminence Grise?
Using molecular biology to maximize concurrent training
Lizabeth Allison Ch:14 Waever Ch 17, 18, 19
Host Translation at the Nexus of Infection and Immunity
Ageing as a Risk Factor for Disease
Figure 1 The insulin signalling pathway
Rapamycin: One Drug, Many Effects
FGFR Signaling as a Target for Lung Cancer Therapy
mTORC1 signalling links cellular growth with autophagy
Autophagy in kidney disease and aging: lessons from rodent models
IRS-1: Auditing the effectiveness of mTOR inhibitors
An Emerging Role of mTOR in Lipid Biosynthesis
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Live Longer sans the AT1A Receptor
Arati Khanna-Gupta  Experimental Hematology 
AKT/PKB Signaling: Navigating the Network
Figure 1 The mTOR signalling pathway
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
AKT/PKB Signaling: Navigating Downstream
Rapamycin: One Drug, Many Effects
mTOR and Akt Signaling in Cancer: SGK Cycles In
Insulin Regulation of Proteostasis and Clinical Implications
Volume 13, Issue 15, Pages (August 2003)
Model of translational regulation by PDGFRα.
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Regulation of mRNA Translation in Neurons—A Matter of Life and Death
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Insulin Regulation of Proteostasis and Clinical Implications
Autophagy in the Cellular Energetic Balance
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Autophagy and the Integrated Stress Response
Lysosomal Rag-ulation of mTOR Complex 1 Activity
Nutrient Sensing, Metabolism, and Cell Growth Control
UPR and cross-talk between apoptosis and metabolism.
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
Presentation transcript:

Hypertrophic signalling Identify contraction-induced growth signals Describe the composition and regulation of mTORC1 Describe the effectors of mTOR Explain the role of mTOR in muscle hypertrophy – Muscle contraction – Diet – Growth factors

Consequences of contraction Intracellular calcium increase ATP (energy) turnover – Muscle: Oxygen depletion, AMP accumulation – Systemic: nutrient mobilization Membrane permeability Growth factor release – Peptides: IGF-1, FGF, HGF – Lipids: PGF2a, PGE2 Systemic hormones – Insulin, GH, adrenaline

Exercise induces mTOR activity Rats trained to lift 60%BW vest Phosphorylation by WB Protein synthesis over 16 h Rapamycin blocks Akt phosphorylation mTOR phosphorylation Bolster & al., 2003 Kubica & al., 2005

Rapamycin blocks hypertrophy Synergist ablation – Cyclosporin to block Cn – Rapamycin to block mTOR CsA muscles hypertrophy Rap muscles don’t Bodine & al., 2001

Why mTOR? Powerful, multiplex regulator of protein synthesis and growth – Translation efficiency – Translational regulation/selection – Protein degradation Activated by diverse growth and function relevant stimuli – Contraction/exercise – Nutrients – Hormones (insulin, IGF, HGH)

Mammalian Target of Rapamycin Deldicque & al., 2005 mTORC Pro-growth stimuli mTOR Protein synthesis (hypertrophy) Contraction p38

Two mTOR Complexes Rapamycin sensitive mTORC1 Composition – mTOR – G  L (mLST8) dispensible – PRAS40 – RAPTOR Regulation – Growth factors (PI3K/akt) – Nutrients (TSC1/2, Rag) – Redox Targets – Ribosomal biogenesis (p70S6k) – Translation (4EBP1) – Autophagy Rapamycin insensitive mTORC2 Composition – mTOR – G  L (mLST8) – PRR5, mSin1 – RICTOR Regulation – Growth factors (PI3K/akt) – mTORC1 (RICTOR) Targets – Cytoskeleton (esp yeast) – Proteasome (Akt  FOXO) – Glycogen synthesis (GSK3) – PKC

Core mTORC1 control Active complex requires Rheb-GTP – Rheb GTPase – GTPase-Activating Protein (GAP) – Guanine Exchange Factor (GEF) – mTOR autophos S2481 TSC 1/2 – Tuberous Sclerosis Complex – Major site of GF/energy reg. GEF unknown/unnecessary – Translationally Controlled Tumor Protein GLGL Rheb-GTP Rheb-GDP RAPTOR mTOR TSC2 TSC1 TCTP(?) Substrate

Growth Factors and “Energy” Phosphatidylinositol 3’ kinase (PI3K) – PIP2  PIP3 – PDK1 – Akt Extracellular-signal Regulated Kinase (ERK) P38  MK2 AMPK (activates TSC2) GSK3 (activates TSC2) Hypoxia – HIF  REDD Rheb-GTPRheb-GDP TSC2 TSC1 Akt ERK2MK2 GSK3 AMPK REDD

Amino Acids Branched-chain AA – Leucine, isoleucine, valine – Rag-GTPase – Ragulator AA-sensitive GEF – Translocation to Rheb-rich lysosomes GLGL RagB-GTP Rag-GDP RAPTOR mTOR TSC2Ragulator Rab7/ lysosome Sanack & al., 2008 Rheb-GTP AA-starved mTOR is distributed through the cytoplasm, and becomes localized to lysosomes rapidly on AA feeding

Growth factors and overload Insulin – Suppressed at low (<60% VO2max) intensity – Neutral at high (>80% VO2max) Insulin-like growth factor-1 – Elevated after resistance exercise (up to 2 days) – Powerful growth stimulator Insulin and IGF-1 Receptors – Insulin receptor substrate 1 (IRS1) – PI3K  Akt – ERK, p38, PLC IGF-1 expression after synergist ablation (Adams & al 2002)

IGF-1 promotes muscle growth Infused into muscle (not systemic) – Activation of Akt, mTOR – p70S6k, 4EBP1 Adams & McCue 1998

Overload seems independent of IGF-1 Muscle hypertrophy by synergist ablation in IGF-1R knockout Cardiac hypertrophy by swim-training in p70S6k knockout Heart weights after 8 weeks swimming (McMullen & al., 2004) Plantaris mass after synergist ablation Spangenburg & al 2008 WTMKR-/- 35 d 7 d 0 d

Amino acid feeding AA feeding alone increases mTOR &PS Protein feeding with exercise gives much better/faster mTOR activation No difference in hypertrophy (22 weeks) mTOR phosphorylation post-exercise with or without protein feeding (Hulmi & al 2009)

Metabolic effects Elevated AMP – AMP Kinase  TSC2 --| mTOR – Permissive? GSK3 – Insulin  Akt--|GSK3 Oxygen – Hypoxia Inducible Factor  REDD  TSC2 – ROS directly oxidize cysteines AICAR-induced activation of AMPK blocks AA-induced protein synthesis (Pruznak & al., 2008)

Intermediate summary Exercise-related stresses tend to block mTOR during exercise and activate mTOR after exercise – Energetic stresses during exercise: Low O2, high AMP – Recovery processes/hormones after exercise Nutrient mobilization Insulin IGF-1 Acute mTOR signaling correlates with hypertrophy under normal conditions – Not in Insulin/IGF-1 receptor defective models – Not in p70 S6k defective models

Correlation and causation Muscle mass gain after 6 weeks HFES correlates with p70S6k phosphorylation at 6 hours. (Baar & Esser 1999) Fold phosphorylation of p70S6k Type II fiber area Placebo Protein Fiber size after 3 weeks training vs p70S6k phosphorylation. (Hulmi & al 2009)

mTOR effectors Ribosome assembly – p70S6k  RPS6 – 5’-TOP mRNAs (ribosome components) Translational efficiency – 4EBP--|eIF4E – Cap dependent translation Transcription factors – Akt/SGK--|FOXO – NFAT3, STAT3 IRS-1 (negative feedback)

Protein translation Initiation – eIF4 recognition and melting of 7’mG cap eIF4E cap-binding subunit 4EBP competition with eIF4F scaffold – Recruit 40S ribosome met-tRNA eIF2 GTP-dependent met-tRNA loader – Recruit 60S ribosome Start codon

Initiation Pre-initiation complex Transition to elongation Fig 17-9

Protein translation Elongation – tRNA recruitment eEF1 GTP-dependent tRNA carrier GTP hydrolysis with peptide bond formation – Ribosome advance eEF2 GTP-dependent procession GTP hydrolysis with advance

Elongation Elongation Cycle eEF1 Cycle Fig eEF2 cycle

3’ untranslated region structure Post-transcriptional control – 2° and 3° structure of mRNA – Analogous to DNA promoter 5’ Tract of Oligopyrimidines – Ribosomal proteins – eEF1, eEF2 “Highly structured” 5’ cap – Ribosome scanning – Growth factors, cell cycle control Internal Ribosome Entry Site (IRES) – Inflammation, angiogenesis Phosphorylated RPS6 favors these Active eIF4 complex favors these

Species differences Most proteins conserved yeast-human Regulatory processes differ S cerevisiae have 2 TORs Drosophila akt doesn’t directly regulate TSC2 C Elegans has no TSC1/2; transcriptional repression of RAPTOR via FOXO S cerevisiae mTOR independent of Rheb

Summary High force contractions induce multiple signaling modes – Metabolites, growth factors, mechanical Hypertrophy closely linked with mTOR – GF signaling – Metabolite signaling mTOR is a powerful control of protein accretion – Makes more ribosomes via p70S6k – General translation efficiency via 4EBP – Reduced degradation via FOXO, NFAT3